Zealand Pharma A/S (NASDAQ:ZEAL)

40.48
Delayed Data
As of Feb 21
 -0.3986 / -0.98%
Today’s Change
14.40
Today|||52-Week Range
44.60
+21.93%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$1.6B

Company Description

Zealand Pharma A/S is a biotechnology company that engages in the discovery, design and development of peptide based medicines. Its products include Soliqua and Lyxumia. The company was founded by Lars Hellerung Christiansen and Bjarne Due Larsen on October 19, 1998 and is headquartered in Glostrup, Denmark.

Contact Information

Zealand Pharma A/S
Smedeland 36
Glostrup Zealand 2600
P:(458) 877-3600
Investor Relations:
(455) 060-3778

Employees

Shareholders

Other institutional6.82%
Mutual fund holders0.66%
Individual stakeholders--

Top Executives

There are no executives to display.